Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Furukawa

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Neurotrauma|June 25, 2003
The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in ratsTetsuya Furukawa, Shigeru Hoshino, Shiro Kobayashi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2018
IL-2-Anti-IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell FunctionsYuichi Yokoyama, Tsuyoshi Iwasaki, Sachie Kitano, et al.
Diabetes & Vascular Disease Research|June 21, 2018
Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trialHiroyuki Takashima, Yoshinori Yoshida, Chinami Nagura, et al.
Cureus|May 12, 2025
Impact of Frailty on the Duration and Type of Speech-Language-Hearing Therapy for Patients With COVID-19Shinichi Watanabe, Takaaki Sakurai, Takahiro Kanaya, et al.
Internal Medicine (Tokyo, Japan)|May 7, 2016
Retroperitoneal Hematoma in a Patient with Advanced Chronic Kidney Disease Receiving Warfarin TherapyTakashi Maruyama, Masanori Abe, Tetsuya Furukawa, et al.
Water Research|January 4, 2011
Accelerated biodegradation of pyrene and benzo[a]pyrene in the Phragmites australis rhizosphere by bacteria-root exudate interactionsTadashi Toyama, Tetsuya Furukawa, Noritaka Maeda, et al.
BMC Nephrology|July 23, 2022
TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case reportTakahide Iwasaki, Kosuke Mizusaki, Miwa Masumoto, et al.
Journal of Chemotherapy (Florence, Italy)|January 12, 2023
Impact of relative dose intensity of trabectedin with pegfilgrastim support: a single-centre retrospective studyYoshimasa Saito, Tatsunori Shimoi, Shintaro Iwata, et al.
Diabetes Technology & Therapeutics|August 7, 2019
Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney DiseaseTakashi Maruyama, Hiroyuki Takashima, Hidetaka Oguma, et al.
Life (Basel, Switzerland)|May 4, 2026
Association Between Time to First Mobilization and Recovery of Oral Intake Function in Patients with Pneumonia: A Two-Center Retrospective Cohort StudyShinichi Watanabe, Takaaki Sakurai, Takahiro Kanaya, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Neurotrauma|June 25, 2003
The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in ratsTetsuya Furukawa, Shigeru Hoshino, Shiro Kobayashi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2018
IL-2-Anti-IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell FunctionsYuichi Yokoyama, Tsuyoshi Iwasaki, Sachie Kitano, et al.
Diabetes & Vascular Disease Research|June 21, 2018
Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trialHiroyuki Takashima, Yoshinori Yoshida, Chinami Nagura, et al.
Cureus|May 12, 2025
Impact of Frailty on the Duration and Type of Speech-Language-Hearing Therapy for Patients With COVID-19Shinichi Watanabe, Takaaki Sakurai, Takahiro Kanaya, et al.
Internal Medicine (Tokyo, Japan)|May 7, 2016
Retroperitoneal Hematoma in a Patient with Advanced Chronic Kidney Disease Receiving Warfarin TherapyTakashi Maruyama, Masanori Abe, Tetsuya Furukawa, et al.
Water Research|January 4, 2011
Accelerated biodegradation of pyrene and benzo[a]pyrene in the Phragmites australis rhizosphere by bacteria-root exudate interactionsTadashi Toyama, Tetsuya Furukawa, Noritaka Maeda, et al.
BMC Nephrology|July 23, 2022
TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case reportTakahide Iwasaki, Kosuke Mizusaki, Miwa Masumoto, et al.
Journal of Chemotherapy (Florence, Italy)|January 12, 2023
Impact of relative dose intensity of trabectedin with pegfilgrastim support: a single-centre retrospective studyYoshimasa Saito, Tatsunori Shimoi, Shintaro Iwata, et al.
Diabetes Technology & Therapeutics|August 7, 2019
Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney DiseaseTakashi Maruyama, Hiroyuki Takashima, Hidetaka Oguma, et al.
Life (Basel, Switzerland)|May 4, 2026
Association Between Time to First Mobilization and Recovery of Oral Intake Function in Patients with Pneumonia: A Two-Center Retrospective Cohort StudyShinichi Watanabe, Takaaki Sakurai, Takahiro Kanaya, et al.
Pageof 5